1 Biologic Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Biologic Therapeutics Drugs Segment by Type
1.2.1 Global Biologic Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Biologic Therapeutics Drugs Segment by Application
1.3.1 Global Biologic Therapeutics Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Biologic Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Biologic Therapeutics Drugs Sales 2017-2028
1.4.3 Biologic Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biologic Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biologic Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Biologic Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Biologic Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologic Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Biologic Therapeutics Drugs Sales by Country
3.3.2 North America Biologic Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Biologic Therapeutics Drugs Sales by Country
3.4.2 Europe Biologic Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Biologic Therapeutics Drugs Sales by Country
3.6.2 Latin America Biologic Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biologic Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Biologic Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Biologic Therapeutics Drugs Price by Type (2017-2022)
5 Global Biologic Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2017-2022)
5.2 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Biologic Therapeutics Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis Biologic Therapeutics Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Biologic Therapeutics Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Smith Medical
6.5.1 Smith Medical Corporation Information
6.5.2 Smith Medical Description and Business Overview
6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
6.5.5 Smith Medical Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Concord Biotech
6.6.1 Concord Biotech Corporation Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
6.7.5 Concord Biotech Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 H. Lundbeck
6.9.1 H. Lundbeck Corporation Information
6.9.2 H. Lundbeck Description and Business Overview
6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
6.9.5 H. Lundbeck Recent Developments/Updates
6.10 Retractable Technologies
6.10.1 Retractable Technologies Corporation Information
6.10.2 Retractable Technologies Description and Business Overview
6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
6.10.5 Retractable Technologies Recent Developments/Updates
7 Biologic Therapeutics Drugs Manufacturing Cost Analysis
7.1 Biologic Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biologic Therapeutics Drugs
7.4 Biologic Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biologic Therapeutics Drugs Distributors List
8.3 Biologic Therapeutics Drugs Customers
9 Biologic Therapeutics Drugs Market Dynamics
9.1 Biologic Therapeutics Drugs Industry Trends
9.2 Biologic Therapeutics Drugs Market Drivers
9.3 Biologic Therapeutics Drugs Market Challenges
9.4 Biologic Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Biologic Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Type (2023-2028)
10.2 Biologic Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Application (2023-2028)
10.3 Biologic Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biologic Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
